StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics cash

Cash and short-term investments held at the end of each period.

Guided Therapeutics's cash was $12.00K at Jun 30, 2026. For fiscal 2025 it was $63.00K, down 83.8% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $3.27M in fiscal 2010.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$63.00K-83.8%
FY2024Dec 31, 2024$388.00K-34.3%
FY2023Dec 31, 2023$591.00K-74.4%
FY2022Dec 31, 2022$2.31M+259.7%
FY2021Dec 31, 2021$643.00K+253.3%
FY2020Dec 31, 2020$182.00K-79.8%
FY2019Dec 31, 2019$899.00K–
FY2018Dec 31, 2018$0-100.0%
FY2017Dec 31, 2017$1.00K-92.9%
FY2016Dec 31, 2016$14.00K-60.0%
FY2015Dec 31, 2015$35.00K-78.4%
FY2014Dec 31, 2014$162.00K-73.6%
FY2013Dec 31, 2013$613.00K-41.3%
FY2012Dec 31, 2012$1.05M-52.5%
FY2011Dec 31, 2011$2.20M-32.7%
FY2010Dec 31, 2010$3.27M+1320.9%
FY2009Dec 31, 2009$230.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.00K-93.5%
Q1 FY2026Mar 31, 2026$369.00K+220.9%
Q4 FY2025Dec 31, 2025$63.00K-83.8%
Q3 FY2025Sep 30, 2025$87.00K-55.2%
Q2 FY2025Jun 30, 2025$185.00K-32.7%
Q1 FY2025Mar 31, 2025$115.00K-74.2%
Q4 FY2024Dec 31, 2024$388.00K-34.3%
Q3 FY2024Sep 30, 2024$194.00K-73.5%
Q2 FY2024Jun 30, 2024$275.00K-79.7%
Q1 FY2024Mar 31, 2024$445.00K-75.8%
Q4 FY2023Dec 31, 2023$591.00K-74.4%
Q3 FY2023Sep 30, 2023$731.00K-72.9%
Q2 FY2023Jun 30, 2023$1.36M+204.5%
Q1 FY2023Mar 31, 2023$1.84M+153.4%
Q4 FY2022Dec 31, 2022$2.31M+259.7%
Q3 FY2022Sep 30, 2022$2.70M+398.5%
Q2 FY2022Jun 30, 2022$446.00K-51.6%
Q1 FY2022Mar 31, 2022$725.00K-41.9%
Q4 FY2021Dec 31, 2021$643.00K+253.3%
Q3 FY2021Sep 30, 2021$541.00K-6.9%
Q2 FY2021Jun 30, 2021$922.00K+20.8%
Q1 FY2021Mar 31, 2021$1.25M+5838.1%
Q4 FY2020Dec 31, 2020$182.00K-79.8%
Q3 FY2020Sep 30, 2020$581.00K–
Q2 FY2020Jun 30, 2020$763.00K–
Q1 FY2020Mar 31, 2020$21.00K+250.0%
Q4 FY2019Dec 31, 2019$899.00K–
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$6.00K-92.1%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$70.00K-5.4%
Q2 FY2018Jun 30, 2018$41.00K+412.5%
Q1 FY2018Mar 31, 2018$76.00K+7500.0%
Q4 FY2017Dec 31, 2017$1.00K-92.9%
Q3 FY2017Sep 30, 2017$74.00K+1750.0%
Q2 FY2017Jun 30, 2017$8.00K–
Q1 FY2017Mar 31, 2017$1.00K–
Q4 FY2016Dec 31, 2016$14.00K–
Q3 FY2016Sep 30, 2016$4.00K–

More Guided Therapeutics figures

See a number that looks wrong?